全球醫療人體增強市場：仿生學、器官/身體部位替換、外骨骼、機器人（2023-2028）

本報告審視了全球醫療人體增強市場，並提供技術評估、產品和服務評論、應用評估、行業影響評估、競爭分析等。

內容

第 1 章執行摘要

第 2 章簡介

• 仿生學概述
• 仿生產品及應用行業
• 仿生學的驅動因素
  • 醫療技術的進步
  • 人口老齡化導致器官衰竭增加
  • 切割事故
  • 外骨骼的用途
  • 機器人替代品
  • 政府研發計劃
  • 收入增加，尤其是在新興國家
• 仿生市場的製約因素
  • 設備和治療成本高昂
  • 政府監管和嚴格的審批流程
  • 缺乏外科專業知識
• 仿生學對社會的影響
  • 積極影響
  • 負面影響

第三章仿生技術與市場發展

• 醫療仿生產品
• 矯形器/假肢
• 人工器官
• 強化外骨骼
  • 醫療外骨骼
  • 軍用外骨骼
  • 輔助外骨骼
• 人體仿生學
• 機械與電子仿生學
• 人工植入物與可穿戴仿生設備
• 3D 打印和仿生學
• 仿生學和人工智能
• 納米技術和仿生學
• 商業仿生學
• 控制論有機體
• 仿生產業現狀

第 4 章用例

• HELLEN - 外骨骼
• 癲癇發作跟蹤和預測
• 適合健身的外骨骼設計
• 機器人外骨骼案例研究
• 重走外骨骼
• 磁性編碼器可以構建“改變生活”的外骨骼
• 靛藍外骨骼

第五章人體增強市場分析與利潤預測

• 仿生總收入（2023-2028 年）
• 按行業劃分的仿生學收入（2023-2028 年）
• 醫療仿生學收入（2023-2028 年）
  • 按產品類別劃分的醫療仿生學收入
  • 按應用類型劃分的醫療仿生學收入
  • 按產品類型劃分的植入式醫療仿生學收入
  • 按技術類型劃分的醫療仿生學收入
  • 按產品類型劃分的醫療機械仿生收入
  • 按最終用戶類型劃分的醫療仿生學收入
  • 醫療仿生學收入：按地區分類
  • 北美醫療仿生學收入：按國家/地區分類
  • 歐洲醫療仿生學收入：按國家分類
  • 亞太地區醫療仿生學收入：按國家/地區劃分
  • 拉丁美洲/中東/非洲的醫療仿生學收入：按國家/地區分類
• 國防外骨骼仿生收入（2023-2028）
  • 按產品類別劃分的國防外骨骼仿生收入
  • 按技術類型劃分的國防外骨骼仿生收入
  • 國防外骨骼仿生收入：按地區
  • 北美國防外骨骼仿生收入（按國家/地區劃分）
  • 亞太地區國防外骨骼仿生收入：按國家分類
  • 歐洲國防外骨骼仿生學收入（按國家劃分）
  • 世界其他地區用於國防的外骨骼仿生學收入：按國家/地區劃分

第六章公司及分析

• 策略建議
• Abbott Laboratories
• AbbVie Inc.
• Abiomed
• Asahi Kasei Kuraray Medical Co. Ltd.
• Baxter International
• Zimmer Biomet Holdings
• Boston Scientific Corporation
• Cochlear Ltd.
• Edwards Lifesciences Corporation
• Ekso Bionics Holdings Inc.
• LivaNova PLC
• Medtronic plc
• Orthofix Holdings Inc.
• Otto Bock HealthCare GmBH
• Sonova Holding AG
• Ossur Corporate
• SynCardia Systems LLC
• Bionic Power
• ExoAtlet
• Lockheed Martin Corporation
• RB3D
• Sarcos Corporation
• Spring Active
• SRI International

第七章結論與市場展望

Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.

In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.

Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.

This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.

Companies in Report:

Table of Contents

1.0. Executive Summary

2.0. Introduction

• 1.1. Bionics Overview
• 1.2. Bionics Products and Application Industry
• 1.3. Bionics Growth Drivers
  • 1.3.1. Healthcare Technology Advancement
  • 1.3.2. Aging Population to Increase Organ Failure
  • 1.3.3. Accident to Amputations
  • 1.3.4. Exoskeleton Application
  • 1.3.5. Substitute of Robotics
  • 1.3.6. Government R&D Initiative
  • 1.3.7. Increase of Income Especially in Emerging Economies
• 1.4. Bionics Market Limitations
  • 1.4.1. High Cost of Device and Treatment
  • 1.4.2. Government Regulations and Strict Approval process
  • 1.4.3. Lack of Surgical Expertise
• 1.5. Bionics Impact on Society
  • 1.5.1. Positive Impact
  • 1.5.2. Negative Impact

2. Bionics Technology and Market Development

• 2.1. Medical Bionics Products
• 2.2. Orthotics and Prosthetics
• 2.3. Artificial Organ
• 2.4. Powered Exoskeleton
  • 2.4.1. Medical Exoskeleton
  • 2.4.2. Military Exoskeleton
  • 2.4.3. Assistive Exoskeleton
• 2.5. Human Bionics
• 2.6. Mechanical vs. Electronics Bionics
• 2.7. Artificial Implants vs. Wearable Bionics
• 2.8. 3D Printing and Bionics
• 2.9. Bionics and Artificial Intelligence
• 2.10. Nanotechnology and Bionics
• 2.11. Business Biomimetic
• 2.12. Cybernetic Organism
• 2.13. Bionics Industry Landscape

3. Use Cases and Examples

• 3.1. HELLEN-The Exoskeleton
• 3.2. Tracking and Predicting Epilepsy Seizures
• 3.3. Designing an Exoskeleton for Fitness
• 3.4. Robotic Exoskeleton Case Study
• 3.5. ReWalk Exoskeleton
• 3.6. Magnetic Encoders Allows the Building of 'Life-Changing' Exoskeletons
• 3.7. Indego Exoskeleton

4. Human Augmentation Market Analysis and Revenue Forecasts

• 4.1. Combined Bionics Revenue 2023-2028
• 4.2. Bionics Revenue by Industry Vertical 2023-2028
• 4.3. Medical Bionics Revenue 2023-2028
  • 4.3.1. Medical Bionics Revenue by Product Category
  • 4.3.2. Medical Bionics Revenue by Application Type
  • 4.3.3. Implantable Medical Bionics Revenue by Product Type
  • 4.3.4. Medical Bionics Revenue by Technology Type
  • 4.3.5. Medical Mechanical Bionics Revenue by Product Type
  • 4.3.6. Medical Bionics Revenue by End User Type
  • 4.3.7. Medical Bionics Revenue by Region
  • 4.3.8. North America Medical Bionics Revenue by Country
  • 4.3.9. Europe Medical Bionics Revenue by Country
  • 4.3.10. APAC Medical Bionics Revenue by Country
  • 4.3.11. LAMEA Medical Bionics Revenue by Country
• 4.4. Defense Exoskeleton Bionics Revenue 2023-2028
  • 4.4.1. Defense Exoskeleton Bionics Revenue by Product Category
  • 4.4.2. Defense Exoskeleton Bionics Revenue by Technology Type
  • 4.4.3. Defense Exoskeleton Bionics Revenue by Region
  • 4.4.4. North America Defense Exoskeleton Bionics Revenue by Country
  • 4.4.5. APAC Defense Exoskeleton Bionics Revenue by Country
  • 4.4.6. Europe Defense Exoskeleton Bionics Revenue by Country
  • 4.4.7. ROW Defense Exoskeleton Bionics Revenue by Country

5. Company and Analysis

• 5.1. Strategic Initiatives
• 5.2. Abbott Laboratories
• 5.3. AbbVie Inc.
• 5.4. Abiomed
• 5.5. Asahi Kasei Kuraray Medical Co. Ltd.
• 5.6. Baxter International
• 5.7. Zimmer Biomet Holdings
• 5.8. Boston Scientific Corporation
• 5.9. Cochlear Ltd.
• 5.10. Edwards Lifesciences Corporation
• 5.11. Ekso Bionics Holdings Inc.
• 5.12. LivaNova PLC
• 5.13. Medtronic plc
• 5.14. Orthofix Holdings Inc.
• 5.15. Otto Bock HealthCare GmBH
• 5.16. Sonova Holding AG
• 5.17. Ossur Corporate
• 5.18. SynCardia Systems LLC
• 5.19. Bionic Power
• 5.20. ExoAtlet
• 5.21. Lockheed Martin Corporation
• 5.22. RB3D
• 5.23. Sarcos Corporation
• 5.24. Spring Active
• 5.25. SRI International

6. Conclusions and Market Outlook

Figures

• Figure 1: Bionics Product and Application Ecosystem
• Figure 2: Bionics Industry Landscape
• Figure 3: Global Bionics Market Revenue 2023 - 2028

Tables

• Table 1: Global Bionics Revenue by Industry Vertical 2023 - 2028
• Table 2: Global Medical Bionics Revenue by Product Category 2023 - 2028
• Table 3: Global Orthopaedic Bionics Revenue by Product Type 2023 - 2028
• Table 4: Global Bionics Limbs Revenue by Product Type 2023 - 2028
• Table 5: Global Bionics Lower Limbs Revenue by Product Type 2023 - 2028
• Table 6: Global Electrical Bone Growth Stimulators Revenue by Product Type 2023 - 2028
• Table 7: Global Cardiac Bionics Revenue by Product Type 2023 - 2028
• Table 8: Global Artificial Organs Revenue by Product Type 2023 - 2028
• Table 9: Global Artificial Heart Valves Revenue by Product Type 2023 - 2028
• Table 10: Global Bionics Pacemaker Revenue by Product Type 2023 - 2028
• Table 11: Global Bionics Ventricular Assist Device (VADs) Revenue by Product Type 2023 - 2028
• Table 12: Global Neural/Brain Bionics Revenue by Product Type 2023 - 2028
• Table 13: Global Bionics Internal Neurostimulators Revenue by Product Type 2023 - 2028
• Table 14: Global Bionics Ear Revenue by Product Type 2023 - 2028
• Table 15: Global Medical Bionics Revenue by Application Type 2023 - 2028
• Table 16: Global Implantable Medical Bionics Revenue by Product Type 2023 - 2028
• Table 17: Global Externally Worn Medical Bionics Revenue by Product Type 2023 - 2028
• Table 18: Global Medical Bionics Revenue by Technology Type 2023 - 2028
• Table 19: Global Medical Mechanical Bionics Revenue by Product Type 2023 - 2028
• Table 20: Global Medical Electronic Bionics Revenue by Product Type 2023 - 2028
• Table 21: Global Medical Bionics Revenue by End User Type 2023 - 2028
• Table 22: Medical Bionics Revenue by Region 2023 - 2028
• Table 23: North America Medical Bionics Revenue by Country 2023 - 2028
• Table 24: Europe Medical Bionics Revenue by Country 2023 - 2028
• Table 25: APAC Medical Bionics Revenue by Country 2023 - 2028
• Table 26: SEA Medical Bionics Revenue by Country 2023 - 2028
• Table 27: LAMEA Medical Bionics Revenue by Country 2023 - 2028
• Table 28: Global Defense Exoskeleton Bionics Revenue by Product Category 2023 - 2028
• Table 29: Global Defense Exoskeleton Revenue by Technology Type 2023 - 2028
• Table 30: Defense Exoskeleton Bionics Revenue by Region 2023 - 2028
• Table 31: North America Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 32: APAC Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 33: Europe Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 34: ROW Defense Exoskeleton Bionics Revenue by Country 2023 - 2028